Some of these mechanisms mediated by CPE may be functioning in other types of cancers as well, to promote cancer progression.10,13,14 Our study together with others suggest that CPE is a potential novel therapeutic target for treating pancreatic cancer. The gene discussed is CPE; the disease is pancreatic neoplasm.